Hutch News
Results per Page:
Ephemeral yet consequential: DUX4 activates an early embryonic program in cancer cells
From the Tapscott lab, Human Biology Division
‘Dux’ and Cover: an enigmatic protein’s potential role in immune evasion
From the Tapscott Lab, Human Biology Division
This little piggie went to the clinic: pigs as a model of DUX4-linked muscular dystrophy
From the Tapscott Lab, Human Biology Division
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
Fred Hutch GSK Partnership - Fred Hutchinson Cancer Research Center
Collaboration represents first U.S. institution chosen to participate in GSK academic-industry partnership
Tapscott Lab's Geng among Weintraub winners
Molecular and cell biologist Linda Geng is one of 13 recipients nationwide of the Center's 2012 Harold M. Weintraub Graduate Student Award
Tapscott team discovers genes, mechanisms of common muscular dystrophy
Discoveries may result in biomarker test for facioscapulohumeral muscular dystrophy, a disease that initially affects the skeletal muscles of the face, scapula and upper arms
International research team discovers genes and disease mechanisms behind a common form of muscular dystrophy
Discovery could lead to a biomarker-based test for diagnosis
‘Dead gene’ plays key role in muscular dystrophy
Tapscott’s global team discovers expression of an MD-causing gene thought to be inactive in humans; work may lead to new therapy targets, evolutionary insights
Muscular dystrophy: zeroing in on a cause
Tapscott, Snider and global research team further understanding of key genetic mutation, reveal possible drug targets